VIVE - Viveve Medical GAAP EPS of -$0.67 beats by $0.01 revenue of $1.64M beats by $0.03M
Viveve Medical press release (NASDAQ:VIVE): Q1 GAAP EPS of -$0.67 beats by $0.01. Revenue of $1.64M (+13.1% Y/Y) beats by $0.03M. Increased the installed base of Viveve Systems to 895 systems worldwide. Cash and cash equivalents were $14.0 million as of March 31, 2022, compared to $19.2 million as of December 31, 2021.
For further details see:
Viveve Medical GAAP EPS of -$0.67 beats by $0.01, revenue of $1.64M beats by $0.03M